Clovis Oncology reported $-50359000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Acorda Therapeutics ACOR:US $ -13503000 3.34M
Agenus AGEN:US $ -35997000 20.08M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
Anika Therapeutics ANIK:US $ -3554000 5.35M
Arrowhead Research ARWR:US $ 41.55M 104.87M
AstraZeneca AZN:LN 2.88B 1.57B
Astrazeneca AZN:US 2.88B 1.57B
Cerulean Pharma CERU:US $ -8400450 1.14M
Clovis Oncology CLVS:US $ -50359000 2.35M
Eli Lilly And LLY:US $ 2569.9M 171.6M
Enanta Pharmaceuticals ENTA:US $ -33847000 3.44M
Esperion Therapeutics ESPR:US $ -42989000 611K
GlaxoSmithKline GSK:LN 2.42B 724M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62923000 9.39M
Insmed INSM:US $ -101451000 1.41M
Intrexon XON:US $ -17414000 3.07M
Ligand Pharmaceuticals LGND:US $ -9306000 22.04M
Merk MRK:US $ 5059M 207M
Mirati Therapeutics MRTX:US $ -184218000 12.86M
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Puma Biotechnology PBYI:US $ -747000 7.58M
Rigel Pharmaceuticals RIGL:US $ -26261000 8.36M
Sangamo Biosciences SGMO:US $ -45261000 5.36M
Seattle Genetics SGEN:US $ -133050000 39.02M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Veracyte VCYT:US $ -15248000 6.72M
YTE INCY:US $ 127.66M 7.71M